SEMPERIT AG HLD EBITDA 2019-2025 | SEIGY
SEMPERIT AG HLD ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
SEMPERIT AG HLD Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $98 |
| 2023 | $76 |
| 2022 | $142 |
| 2021 | $428 |
| 2020 | $162 |
| 2019 | $132 |
| 2018 | $126 |
|
SEMPERIT AG HLD Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $27 |
| 2025-03-31 | $12 |
| 2024-12-31 | $22 |
| 2024-09-30 | $21 |
| 2024-06-30 | $27 |
| 2024-03-31 | $28 |
| 2023-12-31 | $16 |
| 2023-09-30 | $14 |
| 2023-06-30 | $25 |
| 2023-03-31 | $21 |
| 2022-12-31 | $-3 |
| 2022-09-30 | $63 |
| 2022-06-30 | $40 |
| 2022-03-31 | $41 |
| 2021-12-31 | $40 |
| 2021-09-30 | $90 |
| 2021-06-30 | $151 |
| 2021-03-31 | $147 |
| 2020-12-31 | $105 |
| 2020-09-30 | $70 |
| 2020-06-30 | $-31 |
| 2020-03-31 | $19 |
| 2019-12-31 | $11 |
| 2019-09-30 | $75 |
| 2019-06-30 | $26 |
| 2019-03-31 | $19 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.286B | $0.732B |
| Semperit Aktiengesellschaft Holding develops, produces and sells rubber and plastic products for the medical and industrial sectors. Its operating segment consists of Sempermed, Semperflex, Sempertrans and Semperform. Sempermed segment manufactures examination and surgical gloves in the medical area, as well as protective gloves; Semperflex segment develops, produces and sells hydraulic and industrial hoses; Sempertrans segment manufactures textile and steel-cord conveyor belts for use in mining, steel, cement, civil engineering and transport industries, as well as in power stations; Semperform segment manufactures elastomer and insulation profiles for windows, doors, and facades; escalator handrails; vibration-reducing foils for skis and snowboards and custom molded parts and rubber rings for ropeways. Semperit Aktiengesellschaft Holding is based in Vienna, Austria. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.907B | 25.23 |
| EssilorLuxottica (ESLOY) | France | $167.835B | 0.00 |
| Boston Scientific (BSX) | United States | $149.593B | 34.21 |
| Stryker (SYK) | United States | $135.768B | 26.96 |
| Medtronic (MDT) | Ireland | $118.854B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.878B | 0.00 |
| Agilent Technologies (A) | United States | $41.493B | 26.85 |
| ResMed (RMD) | United States | $36.500B | 25.26 |
| GE HealthCare Technologies (GEHC) | United States | $33.472B | 16.01 |
| Koninklijke Philips (PHG) | Netherlands | $27.202B | 17.77 |
| Terumo (TRUMY) | Japan | $24.340B | 28.84 |
| Insulet (PODD) | United States | $22.536B | 69.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.585B | 10.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.234B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.124B | 7.37 |
| Bio-Rad Laboratories (BIO) | United States | $8.292B | 29.81 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| ICU Medical (ICUI) | United States | $3.437B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $3.361B | 10.24 |
| Haemonetics (HAE) | United States | $3.299B | 14.68 |
| Envista Holdings (NVST) | United States | $3.297B | 18.92 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.907B | 13.26 |
| LeMaitre Vascular (LMAT) | United States | $1.992B | 40.09 |
| Curaleaf Holdings (CURLF) | Canada | $1.977B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.961B | 4.91 |
| Phibro Animal Health (PAHC) | United States | $1.858B | 18.56 |
| Green Thumb Industries (GTBIF) | United States | $1.612B | 70.64 |
| AtriCure (ATRC) | United States | $1.590B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.471B | 0.00 |
| Neogen (NEOG) | United States | $1.382B | 26.50 |
| Kestra Medical Technologies (KMTS) | United States | $1.359B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.340B | 8.62 |
| AdaptHealth (AHCO) | United States | $1.272B | 18.43 |
| BioLife Solutions (BLFS) | United States | $1.266B | 375.57 |
| InMode (INMD) | Israel | $0.923B | 10.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.792B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.500B | 17.23 |
| SNDL (SNDL) | Canada | $0.491B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.474B | 0.00 |
| Evolus (EOLS) | United States | $0.457B | 0.00 |
| Omeros (OMER) | United States | $0.449B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.438B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Cerus (CERS) | United States | $0.307B | 0.00 |
| Brainsway (BWAY) | Israel | $0.306B | 62.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.294B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 155.67 |
| High Tide (HITI) | Canada | $0.262B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.254B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.243B | 19.36 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Owens & Minor (OMI) | United States | $0.228B | 2.29 |
| Organigram Global (OGI) | Canada | $0.222B | 0.00 |
| Exagen (XGN) | United States | $0.214B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.210B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.18 |
| FitLife Brands (FTLF) | United States | $0.174B | 21.46 |
| OraSure Technologies (OSUR) | United States | $0.167B | 0.00 |
| Apyx Medical (APYX) | United States | $0.157B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.140B | 0.00 |
| Biote (BTMD) | United States | $0.122B | 4.92 |
| Sharps Technology (STSS) | United States | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 13.49 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.00 |
| Nephros (NEPH) | United States | $0.046B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Zynex (ZYXI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.65 |
| Modular Medical (MODD) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |